TScan Therapeutics Inc. (TCRX)
NASDAQ · Healthcare
TScan Therapeutics Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 10.3M | 2.8M | 21.0M | 13.5M | 10.1M | 1.1M |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -135.8M | -134.8M | -93.5M | -66.6M | -48.6M | -26.2M |
| EBITDA | -132.9M | -130.7M | -88.1M | -61.5M | -45.3M | -25.0M |
| Net Income | -129.8M | -127.5M | -89.2M | -66.2M | -48.6M | -26.1M |
| Per Share Data | ||||||
| EPS (diluted) | $-1.00 | $-1.14 | $-1.36 | $-2.75 | $-4.17 | — |
| Shares Outstanding (dil.) | 130M | 112M | 66M | 24M | 12M | 1M |
TScan Therapeutics Inc. Income Statement — FAQ
TScan Therapeutics Inc. (TCRX) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TCRX's income statement history?
The chart and table above show TScan Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.